If specific subsets of BRCA1mut/+ HMECs normally advance beyond the manifestation of an SFR defect to develop additional BRCA1 functional deficiencies accompanied by a much higher risk of tumorigenicity, their selective elimination might suppress subsequent BRCA1 breast cancer development. This evidence concerns the gene BRCA1 and breast carcinoma.